“Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan” (2026) Physical Education, Health and Social Sciences, 4(1), pp. 129–136. doi:10.63163/jpehss.v4i1.1040.